相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial)
Jelle C. van Dongen et al.
ANNALS OF SURGERY (2022)
Updated Alternative Fistula Risk Score (ua-FRS) to Include Minimally Invasive Pancreatoduodenectomy Pan-European Validation
Timothy H. Mungroop et al.
ANNALS OF SURGERY (2021)
Impact of Neoadjuvant Systemic Therapy on Pancreatic Fistula Rates Following Pancreatectomy: a Population-Based Propensity-Matched Analysis
Fadi S. Dahdaleh et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2021)
The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis
Tara M. Mackay et al.
HPB (2020)
Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study
Sanne Lof et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Impact of neoadjuvant therapy on post-operative pancreatic fistula: a systematic review and meta-analysis
Sivesh K. Kamarajah et al.
ANZ JOURNAL OF SURGERY (2020)
C-reactive protein is superior to white blood cell count for early detection of complications after pancreatoduodenectomy: a retrospective multicenter cohort study
Jelle C. van Dongen et al.
HPB (2020)
Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis
Christopher W. Mangieri et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Benchmarks in Pancreatic Surgery A Novel Tool for Unbiased Outcome Comparisons
Patricia Sanchez-Velazquez et al.
ANNALS OF SURGERY (2019)
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery
Yoshihiro Miyasaka et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Variation in pancreatoduodenectomy as delivered in two national audits
T. M. Mackay et al.
BRITISH JOURNAL OF SURGERY (2019)
Effects of duration of initial treatment on postoperative complications in pancreatic cancer
Suguru Yamada et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2019)
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS) Design and International External Validation
Timothy H. Mungroop et al.
ANNALS OF SURGERY (2019)
Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy
Thomas Hank et al.
JAMA SURGERY (2019)
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study
Nicolo Pecorelli et al.
FRONTIERS IN ONCOLOGY (2019)
Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit
Lennart B. van Rijssen et al.
HPB (2018)
Clinical Impact of Neoadjuvant Therapy on Nutritional Status in Pancreatic Cancer
Mitsuru Tashiro et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
Thomas J. Ettrich et al.
BMC CANCER (2018)
Postoperative pancreatic fistula: a review of traditional and emerging concepts
Christopher B. Nahm et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2018)
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications
Giovanni Marchegiani et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting
Tsutomu Fujii et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma
Hideo Tomihara et al.
SURGERY TODAY (2017)
Risk factors of serious postoperative complications after pancreaticoduodenectomy and risk calculators for predicting postoperative complications: a nationwide study of 17,564 patients in Japan
Shuichi Aoki et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2017)
Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF) A systematic review and analysis of the POPF-related mortality rate in 60,739 patients retrieved from the English literature published between 1990 and 2015
Sergio Pedrazzoli
MEDICINE (2017)
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
Claudio Bassi et al.
SURGERY (2017)
A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma
Benedetto Ielpo et al.
SURGICAL ONCOLOGY-OXFORD (2017)
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial-1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial
Knut Jorgen Labori et al.
BMC SURGERY (2017)
Financial Impact of Postoperative Complication Following Hepato-Pancreatico-Biliary Surgery for Cancer
Faiz Gani et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
Jason W. Denbo et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
Preoperative chemoradiation for pancreatic adenocarcinoma does not increase 90-day postoperative morbidity or mortality
J. Denbo et al.
HPB (2016)
Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer
Eric A. Mellon et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
Cristina R. Ferrone et al.
ANNALS OF SURGERY (2015)
Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets
Riccardo Casadei et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer
Masayuki Sho et al.
LANGENBECKS ARCHIVES OF SURGERY (2015)
Distal pancreatectomy for pancreatic carcinoma in the era of multimodal treatment
F. Paye et al.
BRITISH JOURNAL OF SURGERY (2015)
Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
Amanda B. Cooper et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer
Henriette Golcher et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
508 Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
Amanda Cooper et al.
GASTROENTEROLOGY (2014)
A Multi-Institutional External Validation of the Fistula Risk Score for Pancreatoduodenectomy
Benjamin C. Miller et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2014)
Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery
Fuyuhiko Motoi et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Neoadjuvant Therapy and Vascular Resection During Pancreaticoduodenectomy: Shifting the Survival Curve for Patients with Locally Advanced Pancreatic Cancer
Irene Epelboym et al.
WORLD JOURNAL OF SURGERY (2014)
Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program ( ACS- NSQIP)
Sung W. Cho et al.
HPB (2014)
Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection
K. Sahora et al.
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA (2013)
Preoperative Chemotherapy Does Not Adversely Affect Pancreatic Structure and Short-Term Outcome after Pancreatectomy
Nicolo Pecorelli et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer
Masayuki Sho et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2013)
A Prospectively Validated Clinical Risk Score Accurately Predicts Pancreatic Fistula after Pancreatoduodenectomy
Mark P. Callery et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2013)
Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer
In Rae Cho et al.
PANCREATOLOGY (2013)
Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head
Quentin Denost et al.
HPB (2013)
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy
Giuliano Barugola et al.
AMERICAN JOURNAL OF SURGERY (2012)
The Impact of Vascular Resection on Early Postoperative Outcomes after Pancreaticoduodenectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database
Anthony W. Castleberry et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma
Hidenori Takahashi et al.
SURGERY (2011)
Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival
Louise Barbier et al.
HPB (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Pancreatic resections after chemo radiotherapy for locally advanced ductal adenocarcinoma: Analysis of perioperative outcome and survival
Paolo Massucco et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Postoperative pancreatic fistula: An international study group (ISGPF) definition
C Bassi et al.
SURGERY (2005)
Effects of radiation on normal tissue: consequences and mechanisms
HB Stone et al.
LANCET ONCOLOGY (2003)
分享论文
